Abstract:IntroductionThe contribution of neuroinflammation in cognitive impairment is increasingly recognized. Non-steroidal anti-inflammatory drugs had been proven that it could improve cognitive impairment in large dose but with more side effect, which limited the application. The main objective of this study was to investigate whether the combined use of nicotine and celecoxib could obtain synergistic neuroprotective effect in ischemic rats.MethodsTwenty adult Sprague-Dawley (SD) rats underwent ischemic model surgery by injecting endothelin-1 into the left thalamus, which were classified into four groups with different interventions: nicotine(1.5 mg/kg/d), celecoxib(15 mg/kg/d), nicotine(1.5 mg/kg/d) +celecoxib(15 mg/kg/d), or saline after surgery. The other five SD rats also underwent same surgery by injecting saline instead of endothelin-1, as the control group. Morris water maze (MWM) test was adopted to assess the cognition. Micro PET/CT with 2-[18F]-A-85380 were performed for α4β2-nAChRs detection in vivo. Western blot, real-time PCR and immunohistochemical staining were adopted to detect the expression of α4β2-nAChRs and inflammatory factors which included TNF-α, IL-1β, IL-6 in brain tissue. Microglial activation in the brain was monitored by immunofluorescence with IBA1 staining.ResultsThe MWM test showed rats given with nicotine or celecoxib alone showed much better memory than rats with saline, no difference was observed between nicotine and celecoxib. The rat memory was recovered most significant when the nicotine and celecoxib were combined (p < 0.05). Micro-PET/CT showed much more tracer uptake in the left thalamus and whole brain in rats given with nicotine, or nicotine + celecoxib (nico + cele group) than saline treated rats, whereas the rats given celecoxib did not. Compared with saline treated rats, we found the proteins of α 4nAChR and β2nAChR in rats given nicotine or nico + cele increased significantly, and mRNA/proteins of TNF-α, IL-1β and IL-6 decreased at the same time. The α 4nAChR and β 2nAChR proteins in rats given celecoxib is the same as saline treated rats, whereas the inflammatory factors decreased obviously compared with saline treated rats. Microglial activation was confirmed in saline treated rats, which was inhibited in rats give nicotine, celecoxib or both.ConclusionsThe study revealed the combined use of nicotine and celecoxib may improve the cognitive function in ischemic rats, with a better effect than either alone. Both nicotine and celecoxib can inhibit inflammation, but through different mechanisms: nicotine can activate α4β2-nAChRs while celecoxib is cyclooxygenase-2 inhibitor. Our findings suggest the combined application of two drugs with different anti-inflammation mechanism could attenuate cognitive impairment more effectively in ischemic rats, which may hold therapeutic potential in the clinical practice.

Nicotine-Induced Neuroprotection against Cognitive Dysfunction after Partial Hepatectomy Involves Activation of BDNF/TrkB Signaling Pathway and Inhibition of NF-κB Signaling Pathway in Aged Rats.

Ameliorative Effect of Nicergoline on Cognitive Function Through the PI3K/AKT Signaling Pathway in Mouse Models of Alzheimer's Disease.

Nicotine Induced Neurocognitive Protection and Anti-inflammation Effect by Activating 42 Nicotinic Acetylcholine Receptors in Ischemic Rats

Nicotine induced neurocognitive protection and anti-inflammation effect by activating α4β2 nAChRs in ischemic rats.

Nicotinamide mononucleotide pretreatment improves long-term isoflurane anesthesia-induced cognitive impairment in mice

Nicotine alleviates MPTP-induced nigrostriatal damage through modulation of JNK and ERK signaling pathways in the mice model of Parkinson's disease

JAK2/STAT3 Signaling Pathway Plays a Key Role in Nicotine Mediated Neuroinflammation Suppression in an Ischemic Rat Model

Nicotine Decreases Nerve Regeneration and Pain Behaviors Via PTEN and Downstream Inflammation-Related Pathway in Two Rat Nerve Injury Models.

Preliminary study of the relationship between nicotine improving cognitive function and nicotine-induced anti-inflammatory effect in ischemia rats

Activation of the CD200/CD200R1 axis attenuates neuroinflammation and improves postoperative cognitive dysfunction via the PI3K/Akt/NF-κB signaling pathway in aged mice

Acute nicotine treatment attenuates lipopolysaccharide-induced cognitive dysfunction by increasing BDNF expression and inhibiting neuroinflammation in the rat hippocampus.

NADPH Oxidase 2-Derived Reactive Oxygen Species in the Hippocampus Might Contribute to Microglial Activation in Postoperative Cognitive Dysfunction in Aged Mice.

Anthocyanins Attenuate Neuroinflammation Through the Suppression of MLK3 Activation in a Mouse Model of Perioperative Neurocognitive Disorders

Role of BDNF/ProBDNF Imbalance in Postoperative Cognitive Dysfunction by Modulating Synaptic Plasticity in Aged Mice

Nicotine Activating Α4β2 Nicotinic Acetylcholine Receptors to Suppress Neuroinflammation Via JAK2-STAT3 Signaling Pathway in Ischemic Rats and Inflammatory Cells

Neuroprotective effect of combined use of nicotine and celecoxib by inhibiting neuroinflammation in ischemic rats

Nicotine inhalant via E‐cigarette facilitates sensorimotor function recovery by upregulating neuronal BDNF–TrkB signalling in traumatic brain injury

Dysregulation of BDNF/TrkB Signaling Mediated by NMDAR/Ca2+/calpain Might Contribute to Postoperative Cognitive Dysfunction in Aging Mice

Effect of Combined Application of Nicotine and Celecoxib Attenuating Cognitive Impairments by Inhibiting Inflammation in Ischemic Rats

Nicotine Activating Α 4 Β 2 Nicotinic Acetylcholine Receptors to Suppress Neuroinflammation Via JAK2-STAT3 Signaling Pathway in Ischemic Rats and Inflammatory Cells

Nicotine Ameliorates Experimental Severe Acute Pancreatitis Via Enhancing Immunoregulation of CD4+ CD25+ Regulatory T Cells.